Gastrointestinal tract epithelial changes associated with taxanes: Marker of drug toxicity versus effect

American Journal of Surgical Pathology

Volumn 32, Issue 3, 2008, Pages 473-477

  Daniels, Jason A ^a   Gibson, Michael K ^a   Xu, Li ^a   Sun, Shaoli ^b   Canto, Marcia Irene ^a   Heath, Elisabeth ^a   Wang, Jean ^a   Brock, Malcolm ^a   Montgomery, Elizabeth ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Dianon Systems   (United States)

Author keywords

Chemotherapy; Dysplasia mimic; Mitotic arrest; Ring mitosis; Taxanes; Taxol; Taxol toxicity

Indexed keywords

DOCETAXEL; PACLITAXEL; TAXANE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ACUTE APPENDICITIS; ADULT; AGED; APOPTOSIS; APPENDECTOMY; ARTICLE; BIOPSY TECHNIQUE; BREAST CANCER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GASTROINTESTINAL TRACT; HUMAN; HUMAN TISSUE; HYPERPLASIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MITOSIS; MITOSIS INHIBITION; POSTOPERATIVE PERIOD; SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; COLCHICINE; EPITHELIUM; ESOPHAGUS; FEMALE; GASTRIC MUCOSA; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MITOSIS; PACLITAXEL; TAXOIDS;

EID: 40849118454     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181582331     Document Type: Article

References (19)

1. Clinical Brochure for Taxol (NSC 125975), Division of Cancer Treatment, National Cancer Institute, Bethesda, MD, 1983.
2. Colucci G, Thaler W, Dejaco H, et al. Colonic rupture in a patient on combination chemotherapy for metastasized carcinoma of the esophagogastric junction. Case report and review of the literature. Onkologie. 2005;28:204-206.
3. D'Amato G, Rocha Lima C, Mahany JJ, et al. Neutropenic enterocolitis (typhilitis) associated with docetaxel therapy in a patient with non-small-cell lung cancer: case report and review of literature. Lung Cancer. 2004;44:381-390.
4. de Haan D, van den Berg M. Colonic perforation secondary to Taxol therapy: an unusual presentation. Onkologie. 2006;29:541-542.
5. Debernardis D, Sire EG, De Feudis P, et al. p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res. 1997;57:870-874.
6. Haldar S, Chintapalli J, Croce CM. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 1996;56:1253-1255.
7. Hruban RH, Yardley JH, Donehower RC, et al. Taxol toxicity. Epithelial necrosis in the gastrointestinal tract associated with polymerized microtubule accumulation and mitotic arrest. Cancer. 1989;63:1944-1950.
8. Iacobuzio-Donahue CA, Lee EL, Abraham SC, et al. Colchicine toxicity: distinct morphologic findings in gastrointestinal biopsies. Am J Surg Pathol. 2001;25:1067-1073.
9. Kouroussis C, Samonis G, Androulakis N, et al. Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases. Am J Clin Oncol. 2000;23:309-313.
10. Milross CG, Mason KA, Hunter NR, et al. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst. 1996;88:1308-1314.
11. Pestalozzi BC, Sotos GA, Choyke PL, et al. Typhlitis resulting from treatment with Taxol and doxorubicin in patients with metastatic breast cancer. Cancer. 1993;71:1797-1800.
12. Rose PG, Piver MS. Intestinal perforation secondary to paclitaxel. Gynecol Oncol. 1995;57:270-272.
13. Rowinsky EK, Donehower RC. Paclitaxel (Taxol). N Engl J Med. 1995;332:1004-1014.
14. Schimming R, Mason KA, Hunter N, et al. Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel. Cancer Chemother Pharmacol. 1999;43:165-172.
15. Seewaldt V, Cain JM, Greer BE, et al. Bowel complications with Taxol therapy. J Clin Oncol. 1993;11:1198.
16. Seewaldt VL, Cain JM, Goff BA, et al. A retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian cancer. Gynecol Oncol. 1997;67:137-140.
17. Tishler RB, Lamppu DM, Park S, et al. Microtubule-active drugs Taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Res. 1995;55:6021-6025.
18. Torres K, Horwitz SB. Mechanisms of Taxol-induced cell death are concentration dependent. Cancer Res. 1998;58:3620-3626.
19. Woods CM, Zhu J, McQueney PA, et al. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med. 1995;1:506-526.